Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis
Damien Etchecopar‐Etchart, Théo Korchia, Anderson Loundou, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 298-308
Open Access | Times Cited: 79

Showing 26-50 of 79 citing articles:

Poverty and inequality in real-world schizophrenia: a national study
Guillaume Fond, Dong Keon Yon, Bach Xuan Tran, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 10
Factors associated with death, hospitalization, resignation, and sick leave from work among patients with schizophrenia in Japan: a nested case–control study using a large claims database
Ken Inada, Yoshitaka Saito, Kenji Baba, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The Community Assessment of Psychic Experiences: Optimal cut‐off scores for detecting individuals with a psychotic disorder
Edo S. Jaya, Thérèse van Amelsvoort, Agna A. Bartels‐Velthuis, et al.
International Journal of Methods in Psychiatric Research (2021) Vol. 30, Iss. 4
Open Access | Times Cited: 21
Pleiotropic Association of CACNA1C Variants With Neuropsychiatric Disorders
Zuxing Wang, Xiandong Lin, Xinqun Luo, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 5, pp. 1174-1184
Open Access | Times Cited: 8
Effects of COVID-19-related stress and fear on depression in schizophrenia patients and the general population
Yu‐Ri Lee, Young‐Chul Chung, Jung‐Jin Kim, et al.
Schizophrenia (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Remote digital phenotyping in serious mental illness: Focus on negative symptoms, mood symptoms, and self-awareness
Michelle Miller, Ian M. Raugh, Gregory P. Strauss, et al.
Biomarkers in Neuropsychiatry (2022) Vol. 6, pp. 100047-100047
Open Access | Times Cited: 11
Identification of 64 new risk loci for major depression, refinement of the genetic architecture and risk prediction of recurrence and comorbidities
Thomas D. Als, Mitja Kurki, Jakob Grove, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Is too much insight bad for you?
Javier-David López-Moríñigo, Anthony S. David
The British Journal of Psychiatry (2024) Vol. 225, Iss. 4, pp. 454-457
Open Access | Times Cited: 2
Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up
Dongmei Han, Daliang Sun, Meihong Xiu, et al.
Psychoneuroendocrinology (2021) Vol. 133, pp. 105392-105392
Closed Access | Times Cited: 13
Untreated major depression in healthcare workers: Results from the nationwide AMADEUS survey
Guillaume Fond, Guillaume Lucas, Laurent Boyer
Journal of Clinical Nursing (2023) Vol. 32, Iss. 21-22, pp. 7765-7772
Open Access | Times Cited: 5
Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects
Arto Puranen, Marjaana Koponen, Markku Lähteenvuo, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Effects of COVID-19 pandemic on depression in patients with schizophrenia: A mini-review of the current evidence
Homa Seyedmirzaei, Saba Katebian, Donya Pourkand, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 143-149
Open Access | Times Cited: 4
Analysis of MicroRNA-Transcription Factors Co-Regulatory Network Linking Depression and Vitamin D Deficiency
Maria Sala-Cîrtog, Ioan Ovidiu Sîrbu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1114-1114
Open Access | Times Cited: 1
Clinical Features of Depressive Disorders
Ian Anderson, Kate Williams-Markey
Cambridge University Press eBooks (2024), pp. 64-88
Closed Access | Times Cited: 1
Challenges and Future Research Directions in Automated Detection of Mental Illness Using Machine Learning
Sadiq Hussain
Academic Bulletin of Mental Health (2024) Vol. 2, pp. 56-60
Closed Access | Times Cited: 1
A cross-section study of the comparison of plasma inflammatory cytokines and short-chain fatty acid in patients with depression and schizophrenia
Huan Yu, Rui Li, Xue‐jun Liang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Prevalence of treatment-resistant depression and associated factors among major depressive disorder follow-up patients at Saint Amanuel Mental Specialised Hospital in Ethiopia: a cross-sectional study
Merga Siyoum, Esayas Kibrom, Tolesa Fanta Jilcha, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e087006-e087006
Open Access | Times Cited: 1
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort
O. Godin, Baptiste Pignon, Andreı̈ Szöke, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110641-110641
Open Access | Times Cited: 6
The financial situation before and after first-time psychiatric in-patient diagnosis of schizophrenia spectrum, bipolar, and major depressive disorder
Marcus Eliason
Economics & Human Biology (2023) Vol. 49, pp. 101231-101231
Closed Access | Times Cited: 3
Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia
Arnim Johannes Gaebler, Ekkehard Haen, Nagia Ben Omar, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 3
Moment-to-moment affective dynamics in schizophrenia and bipolar disorder
Suzanne Ho‐wai So, Anson Kai Chun Chau, Lawrence Kin-hei Chung, et al.
European Psychiatry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 3
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset
D. Misdrahi, Maud Dupuy, Yecodji Dansou, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Classifying Schizophrenia Cases by Artificial Neural Network Using Japanese Web-Based Survey Data: Case-Control Study
Yupeng He, Masaaki Matsunaga, Yuanying Li, et al.
JMIR Formative Research (2023) Vol. 7, pp. e50193-e50193
Open Access | Times Cited: 3
Pain Sensitivity in Schizophrenia Spectrum Disorders: A Narrative Review of Recent Work
Alexandre González-Rodríguez, Javier Labad, Mary V. Seeman
Psychiatry International (2021) Vol. 2, Iss. 1, pp. 48-58
Open Access | Times Cited: 7
Revealing the impact of psychiatric comorbidities on treatment outcome in early psychosis using counterfactual model explanation
Violet van Dee, Seyed Mostafa Kia, Inge Winter-van Rossum, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 2

Scroll to top